Suntheanine (L-Theanine).

Caffeine blocks adenosine receptors, which raises alertness and also the jittery edge that comes with it. Theanine raises alpha wave activity and takes the edge off without removing the alertness, which is why the two are the most studied combination in this category.

Anhydrous caffeine is the same molecule in a dry, fast-dissolving form, so the theanine pairing works identically. Formulas commonly run roughly two parts theanine to one part caffeine.

Theanine and caffeine occur together in the tea leaf, and green tea extract carries both plus the catechins. Adding isolated theanine shifts the leaf's own ratio toward the calmer side.

Shade-grown matcha is unusually high in theanine relative to its caffeine, which is the reason its stimulation reads smoother than coffee. Added theanine pushes that ratio further.

Suntheanine is a branded pure L-isomer theanine, so a second theanine line adds to the same total. The branded form differs by isomer purity, not by mechanism.

Theanine is a glutamine analogue that crosses the blood brain barrier on the L-type large neutral amino acid carrier, the same route tyrosine uses. Large simultaneous doses compete for that carrier.

Theanine is structurally close to glutamine and shares its transport and some of its handling. A heavy glutamine load can crowd theanine on the same carriers.

Magnesium sits in the NMDA receptor channel and damps excitatory glutamate signalling, while theanine modulates glutamate binding and raises alpha activity. Two different points on the same excitatory-inhibitory balance.

Glycine is itself an inhibitory neurotransmitter and lowers core body temperature ahead of sleep onset, a mechanism theanine does not share.

Melatonin signals circadian timing while theanine lowers the mental activation that delays sleep onset. Timing and calm are separate levers on the same evening.

Apigenin binds benzodiazepine sites on the GABA-A receptor while theanine works upstream on glutamate signalling and alpha rhythm. Two distinct entry points.

Lemon balm's rosmarinic acid slows GABA transaminase, keeping GABA in circulation longer, a mechanism separate from theanine's action on glutamate signalling.

Theanine is hydrolysed to glutamate, and glutamate decarboxylase converts glutamate to GABA using pyridoxal-5-phosphate as its cofactor. Without adequate B6 that decarboxylation step runs poorly. The relationship is a settled cofactor dependency in the pathway theanine feeds, not a tested combination.

Theanine enters the brain on the large neutral amino acid transporter LAT1, the same carrier tryptophan uses. Taken together in quantity they compete for a limited number of transport sites. Spacing them apart is ordinary formulation practice rather than a safety issue.

Phenylalanine is one of the large neutral amino acids that share LAT1 with theanine at the blood brain barrier. A large phenylalanine dose reduces the fraction of theanine crossing at the same moment. This is transporter kinetics, measured in transport studies rather than in clinical outcomes.

Leucine is a high-affinity LAT1 substrate, so a branched-chain amino acid load competes with theanine for brain entry. The competition is dose dependent and transient. It is a reason to separate a pre-workout amino blend from a theanine dose, not a reason to avoid either.

Magnesium sits in the NMDA receptor channel as a voltage-dependent block, and theanine interacts weakly with the same ionotropic glutamate receptor family. Both are used in evening formulas aimed at winding down. The combination is mechanistically coherent; head-to-head human work on the pair is thin.

Taurine acts at glycine and GABA-A receptors and behaves as an osmolyte in neural tissue. Theanine works on the glutamatergic side of the same balance. Pairing them targets both arms of excitatory and inhibitory tone, which is why they appear together in calm-focus products.

Oral GABA crosses the blood brain barrier poorly and much of its reported effect is attributed to peripheral and enteric receptors. Theanine does cross on LAT1. The pair is common in relaxation formulas and the two act at different points, so the labelling should say which effect comes from which.

5-HTP is decarboxylated to serotonin, giving a different route into evening calm than theanine's glutamatergic route. Both are staples of sleep-support blends. There is little controlled work on the two together, so read the pairing as formulation logic rather than tested effect.

Valerian constituents modulate GABA-A signalling, and theanine shifts glutamate and GABA tone from a different angle. Stacked in an evening product the calming effects would be expected to add rather than act independently, though the pair has not been tested together. Anyone driving or operating machinery should account for possible additive drowsiness.

Passionflower flavonoids are described as GABA-A positive modulators in preclinical work. Combined with theanine the sedative effect is additive rather than independent. Human data on the specific pair is limited.

Apigenin-bearing chamomile preparations bind benzodiazepine sites in binding assays, a different mechanism from theanine's. The two appear together in night-time teas and capsules. Count the pairing as traditional practice with mechanistic support, not as clinical evidence.

Honokiol and magnolol are described as GABA-A modulators in preclinical models. Layered with theanine the calming effects combine. Doses of both are usually kept modest in evening blends for that reason.

Ashwagandha extracts are studied for effects on the hypothalamic pituitary adrenal axis and cortisol readings, which is a hormonal route. Theanine works on fast neurotransmission instead. The two cover different timescales of the stress response, which is why they are stacked.

Rhodiola is used for alertness under fatigue while theanine takes the edge off stimulation. In a daytime formula they pull in opposite directions on purpose, the same logic that makes the caffeine pairing popular. Controlled work on this specific combination is scarce.

Bacosides are studied over weeks for memory-related measures, whereas theanine acts within an hour. A blend covering both timeframes is a formulation choice with separate rationales. No trial of the pair grounds a combined claim.

Alpha-GPC supplies choline for acetylcholine synthesis, supporting the cholinergic side of attention. Theanine contributes on the glutamatergic side. The stack is built on two established precursor and modulator roles rather than on a combination trial.

CDP-choline delivers choline and cytidine into phospholipid and acetylcholine synthesis. Paired with theanine in focus formulas the two act on different transmitter systems. Read it as mechanistic rather than clinical.

Phosphatidylserine is a membrane phospholipid studied around cortisol response to exertion. It sits alongside theanine in stress-oriented formulas without sharing a pathway with it. The rationale is complementary, and the pair has not been isolated in a trial.

Lion's mane is studied for nerve growth factor related signalling over weeks of use. Theanine's effect is same-day. Combining them in a nootropic blend covers two different time horizons, which is the honest way to describe the pairing.

Inositol feeds phosphoinositide second-messenger signalling downstream of several neurotransmitter receptors. Theanine acts at the receptor level. The two are stacked in calm-support powders on that complementary logic alone.